As the pharmaceutical and healthcare industries grow, pharmaceutical cold chain packaging will gain popularity. According to Future Market Insights, sales of pharmaceutical cold chain packaging are predicted to expand at a CAGR of 14.9 percent between 2021 and 2031. The existence of multiple companies has fragmented the worldwide pharmaceutical cold chain packaging market. However, the majority of the major producers are concentrated in India, China, and the United States.
The market is likely to increase significantly as new players build manufacturing facilities in developing countries such as India, Brazil, and Malaysia. The market penetration is so low that it will expand tenfold in the future years.
Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13956
Several market companies have been drawn to Asian countries by low production costs, simple access to labour, and cheap availability of raw materials. In the pharmaceutical cold chain packaging market, this trend is also evident.
Demand for safe packaging materials is increasing in the pharmaceutical industry. Expansion of pharmaceutical delivery chains has fuelled the demand for solutions to allow storage of products in the prescribed cold temperature so that they don’t undergo any chemical reaction or change their formulation, which could be dangerous for the consumers. These factors are expected to bode well for the market.
Key Takeaways from Pharmaceutical Cold Chain Packaging Market
- By packaging format, active packaging is expected to grow by 4.5x times by 2031.
- By product, the demand for large sized pallet containers is expected to increase at a CAGR of 16.6% during the period of 2021-2031.
- By material, paper is expected to create an incremental opportunity of US$ 10.5 Bn during the forecast period.
- By application, vaccine and diagnostics segment is expected to hold a value market share of 44.1% in 2021.
- By end use, vaccine packaging industry is expected register Y-o-Y growth of 17.1% in 2021.
- The U.S. pharmaceutical cold chain market is expected to reach a market value of US$ 7.0 Bn by 2031.
- India is expected to be the most lucrative market across South Asia
- China and Germany are expected to spearhead the growth of East Asia and Europe market during the forecast period.
“Sales of sustainable pharmaceutical cold chain packaging solutions are driven by the need for more ecological packaging with improved tracking. Steered by increasing demand, market players are expected to focus on strategic collaborations. This also will help them expand their footprint globally” says FMI analyst.
Request TOC @ https://www.futuremarketinsights.com/toc/rep-gb-13956
Commencement of Inoculation Across the Globe will Improve the Pharmaceutical Cold Chain Packaging Market Demand
With the pressure to distribute the COVID-19 vaccine worldwide and to address the seasonal demand for flu shots, pharmaceutical companies are largely depending on cold chain packaging companies to deliver their products in a faster, convenient and hassle-free manner. It is improving the value of the cold chain packaging market and giving rise to innovations and technological advancements.
Collaborations and Integrations Among Key Players to Boost Market Demand
Due to the slight disruption in supply chain due to COVID-19, pharmaceutical companies are involving multiple players to fulfil delivery across the globe. With multiple companies involved, multiple touchpoints for delivery are created and the product could be easily tracked in this process. Several companies are integrating with logistic providers to create a special logistic chain that can carry the processes like warehousing, logistics, delivery and shipment with lower costs.
Market Landscape
Sonoco ThermoSafe, Cold Chain Technologies, Sealed Air Corporation, Nordic Cold Chain Solutions, Cryopak, CSafe Global LLC, TemperPack Technologies, Inc., Insulated Product Corp., Global Cooling, Inc., Envirotainer AB, va-Q-tec AG, EMBALL’ISO, Softbox Systems, Sofrigam SAS, DGP Intelsius LLC, Tempack Packaging Solutions SL, TOWER Cold Chain Solutions, Pelican BioThermal LLC, Blue Star Limited, BIOBASE Group, Andores New Energy Co., Ltd., Haier Biomedical Co. Ltd., Tamai Kasei Co., Ltd., Dhruvraj Syndicate, Valor Industries, KODIAKOOLER, WoolCool Ltd., and Allwin Roto Plast are few of the market players in the pharmaceutical cold chain packaging market.
Tier one market players hold 10% to 15% of the total global pharmaceutical cold chain packaging market. As per FMI, tier-1 players include Sonoco ThermoSafe, Sealed Air Corporation, and Nordic Cold Chain Solutions. Sonoco ThermoSafe is expected to contribute approximately 3 to 4% to the total pharmaceutical cold chain packaging market share.
For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-13956
Pharmaceutical Cold Chain Packaging Market by Category
By Packaging Format:
- Passive Packaging
- Single Use or One Way Use Packaging
- Multiple Use or Re-Usable Packaging
- Active Packaging
- Reefer Trucks and Containers
- Active Pallet Containers
By Product:
- Small Boxes
- Pallets
- Single Pallets
- Double Pallets
- Large sized Pallet Containers
By Material:
- Polymer
- Polyethylene
- Polypropylene
- PET
- EPS
- Polyurethane
- Others
- Metal
- Paper
By Application:
- Biologics and Biological Samples
- Vaccines and Diagnostics
- Others
By End-Use:
- Diagnostic Centers
- Clinical Research Organization
- Blood Banks
- Vaccines Packaging Industry
- Pharmaceuticals
- Other Healthcare Units
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)